https://www.selleckchem.com/pr....oducts/baricitinib-l
group (P0.05). TACE in combination with thalidomide-mediated adjuvant treatment has revealed a promising clinical outcome on HCC patients by downregulating the levels of VEGF and bFGF. TACE in combination with thalidomide-mediated adjuvant treatment has revealed a promising clinical outcome on HCC patients by downregulating the levels of VEGF and bFGF. To explore the effect of using regional cerebral oxygen saturation (rScO ) monitoring with near-infrared spectroscopy in peri-anesthesia management of elderly hypertensi
Like
Comment
Share